\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ none\\ to\\ date\ \(2\)\
\-\ intraconal\\ mass\\ lesion\\:\\ marked\\ enlargement\\ of\\ optic\\ nerve\\ and\\ nerve\\ sheath\\ from\\ the\\ back\\ of\\ the\\ globe\\ through\\ the\\ orbit\\,\\ optic\\ \\ canal\\,\\ and\\ extending\\ to\\ the\\ chiasm\\.\ \(0\)\
\-\ optic\\ nerve\\ glioma\ \(11\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ rhabdomyosarcoma\ \(2\)\
\-\ \\â\\€\\¢\\ optic\\ nerve\\ glioma\ \(0\)\
\-\ 14\\ y\\.o\\.\\ boy\\ with\\ gradual\\ visual\\ loss\\ in\\ right\\ eye\ \(1\)\
\-\ up\\ to\\ 1\\/2\\ of\\ pediatric\\ optic\\ nerve\\ gliomas\\ are\\ seen\\ in\\ patients\\ with\\ neurofibromatosis\\ type\\ 1\\ \\(nf\\-1\\)\\.\\ \\ however\\,\\ this\\ patient\\ had\\ careful\\ evaluation\\,\\ and\\ has\\ no\\ stigmata\\ or\\ features\\ of\\ nf\\-1\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ optic\\:\\ 0\\.5179177097293922\ \(0\)\
\-\ nerve\\:\\ 0\\.4292217943896293\ \(0\)\
\-\ glioma\\:\\ 0\\.2044442346576991\ \(0\)\
\-\ stigmata\\:\\ 0\\.16319381600128974\ \(0\)\
\-\ intraconal\\:\\ 0\\.15295214512760832\ \(0\)\
\-\ gliomas\\:\\ 0\\.13915772321086722\ \(0\)\
\-\ gradual\\:\\ 0\\.13602683881708244\ \(0\)\
\-\ careful\\:\\ 0\\.13330114834656745\ \(0\)\
\-\ chiasm\\:\\ 0\\.12771752242956114\ \(0\)\
\-\ globe\\:\\ 0\\.12539707994032626\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.12177194000685959\ \(0\)\
\-\ sheath\\:\\ 0\\.11966070346416871\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.11932849565282949\ \(0\)\
\-\ orbit\\:\\ 0\\.11144503766351324\ \(0\)\
\-\ date\\:\\ 0\\.11121942310598806\ \(0\)\
\-\ pediatric\\:\\ 0\\.1077127268303805\ \(0\)\
\-\ visual\\:\\ 0\\.1026662339439981\ \(0\)\
\-\ features\\:\\ 0\\.0968232642140265\ \(0\)\
\-\ eye\\:\\ 0\\.09626368869660137\ \(0\)\
\-\ the\\:\\ 0\\.09604252576140902\ \(0\)\
\-\ of\\:\\ 0\\.09419390527343288\ \(0\)\
\-\ canal\\:\\ 0\\.09262111747715901\ \(0\)\
\-\ enlargement\\:\\ 0\\.09225264068393964\ \(0\)\
\-\ marked\\:\\ 0\\.09101141445505297\ \(0\)\
\-\ to\\:\\ 0\\.09024843090686425\ \(0\)\
\-\ meningioma\\:\\ 0\\.090167511520874\ \(0\)\
\-\ 14\\:\\ 0\\.08983918177922941\ \(0\)\
\-\ boy\\:\\ 0\\.0823152094229291\ \(0\)\
\-\ extending\\:\\ 0\\.08158676551623942\ \(0\)\
\-\ type\\:\\ 0\\.08072343234423177\ \(0\)\
\-\ back\\:\\ 0\\.08025289774185514\ \(0\)\
\-\ and\\:\\ 0\\.0745955194697674\ \(0\)\
\-\ evaluation\\:\\ 0\\.07338531810691813\ \(0\)\
\-\ loss\\:\\ 0\\.07331077824121528\ \(0\)\
\-\ through\\:\\ 0\\.07163088385308823\ \(0\)\
\-\ however\\:\\ 0\\.07122258542843914\ \(0\)\
\-\ patients\\:\\ 0\\.06769343597344235\ \(0\)\
\-\ none\\:\\ 0\\.06576077903393336\ \(0\)\
\-\ had\\:\\ 0\\.059953919692441564\ \(0\)\
\-\ in\\:\\ 0\\.05986948554456773\ \(0\)\
\-\ up\\:\\ 0\\.059523798469566194\ \(0\)\
\-\ lesion\\:\\ 0\\.057689927161713235\ \(0\)\
\-\ seen\\:\\ 0\\.056651419184458915\ \(0\)\
\-\ has\\:\\ 0\\.05496423669119826\ \(0\)\
\-\ normal\\:\\ 0\\.0491308249625312\ \(0\)\
\-\ from\\:\\ 0\\.04779084299588058\ \(0\)\
\-\ with\\:\\ 0\\.04712509305469429\ \(0\)\
\-\ mass\\:\\ 0\\.045963683018004936\ \(0\)\
\-\ are\\:\\ 0\\.04566059217108397\ \(0\)\
\-\ or\\:\\ 0\\.04186142506643599\ \(0\)\
\-\ this\\:\\ 0\\.041348306349669524\ \(0\)\
\-\ right\\:\\ 0\\.039895098730508165\ \(0\)\
\-\ patient\\:\\ 0\\.03913801951568328\ \(0\)\
\-\ no\\:\\ 0\\.03913065788237019\ \(0\)\
